Hangzhou Alltest Biotech Co., Ltd. (SHA:688606)
China
· Delayed Price · Currency is CNY 64.55
+0.04 (0.06%)
May 30, 2025, 3:00 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Infectious Diseases | 275.28M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Infectious Diseases Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Drug and Substance Abuse | 203.78M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Drug and Substance Abuse Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| COVID-19 Testing | 89.03M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Women's Health | 70.91M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Women's Health Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Tumor | 19.90M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Tumor Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cardiac Muscle | 13.41M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Business | 2.44M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 79.94M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rapid Diagnostic Reagents | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rapid Diagnostic Reagents Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Heart | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Heart Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Abroad | 694.51M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Abroad Growth | -74.11% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China | 57.75M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | -91.81% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| America | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| America Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Africa | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Africa Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Oceania | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Oceania Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|